4.5. IC50 Assay

CY Chenpeng Yao
ZS Zheyuan Shen
LS Liteng Shen
KK Kailibinuer Kadier
JZ Jingyi Zhao
YG Yu Guo
LX Lei Xu
JC Ji Cao
XD Xiaowu Dong
BY Bo Yang
ask Ask a question
Favorite

Initially, the tested compound was dissolved in DMSO to make a 10 mM stock solution, and the stock solution was then diluted to a drug solution with 50× test concentrations for later use, wherein the test concentrations were reached through dilution at a 10-fold gradient and were 0.1 nM, 1 nM, 10 nM, 100 nM, 1000 nM, 10,000 nM, respectively. Firstly, 2× ATP and substrate solution and 2× kinase and metal solution was prepared using assay buffer (MgCl2 2 mM, MnCl2 1 mM, SEB 12.5 nM, DTT 0.5 mM). From each well of the 96-well plate, 25 μL of the drug solution was taken and then transferred to a 384-well plate which was provided with 2 duplicate wells. Then, 2.5 μL of 2× kinase and metal solution was mixed and incubated in a polystyrene-coated 384-assay plate for 10 min at 25 °C. Then, 2× XL665 and antibody solution was prepared with detection buffer. An amount of 5 μL of Kinase Detection Reagent was added to the well, and incubated for 60 min at 25 °C. The fluorescence signals of 620 nm (Cryptate) and 665 nm (XL665) were read by a microtiter-plate reader. At last, the IC50 value of JNK3 kinase was calculated with the following equations.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A